AMENDMENT NO. 1 TO THE DEVELOPMENT AND LICENSE AGREEMENT between GW PHARMA LTD and OTSUKA PHARMACEUTICAL CO., LTD and GW PHARMACEUTICALS PLCDevelopment and License Agreement • March 26th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 26th, 2013 Company Industry JurisdictionTHIS AMENDMENT NO. 1 (“Amendment”) to that certain Development and License Agreement dated February 14, 2007 by and among the parties hereto (“Agreement”), is made and entered into as of November 1, 2008 (“Amendment Effective Date”), by and among GW Pharma Ltd a corporation organized and existing under the laws of England having offices at Porton Down Science Park, Salisbury, Wiltshire, SP4 OJQ, United Kingdom on behalf of itself and its Affiliates (collectively “GW Pharma”), GW Pharmaceuticals Plc, a company organized under the laws of England, having offices at Porton Down Science Park, Salisbury, Wiltshire, SP4 OJQ, United Kingdom and Otsuka Pharmaceutical Co., Ltd., a corporation organized and existing under the laws of Japan, having a principal place of business at 2-9, Kanda Tsukasamachi, Chiyoda-ku, Tokyo, 101-8535 Japan (“Otsuka”).
AMENDMENT NO. 1 TO THE DEVELOPMENT AND LICENSE AGREEMENT between GW PHARMA LTD and OTSUKA PHARMACEUTICAL CO., LTD and GW PHARMACEUTICALS PLCDevelopment and License Agreement • January 17th, 2013 • Gw Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledJanuary 17th, 2013 Company Industry JurisdictionTHIS AMENDMENT NO. 1 (“Amendment”) to that certain Development and License Agreement dated February 14, 2007 by and among the parties hereto (“Agreement”), is made and entered into as of November 1, 2008 (“Amendment Effective Date”), by and among GW Pharma Ltd a corporation organized and existing under the laws of England having offices at Porton Down Science Park, Salisbury, Wiltshire, SP4 OJQ, United Kingdom on behalf of itself and its Affiliates (collectively “GW Pharma”), GW Pharmaceuticals Plc, a company organized under the laws of England, having offices at Porton Down Science Park, Salisbury, Wiltshire, SP4 OJQ, United Kingdom and Otsuka Pharmaceutical Co., Ltd., a corporation organized and existing under the laws of Japan, having a principal place of business at 2-9, Kanda Tsukasamachi, Chiyoda-ku, Tokyo, 101-8535 Japan (“Otsuka”).